key: cord-0284603-tqvvdkrz
authors: Adam, Lukas; Stanifer, Megan; Springer, Fabian; Mathony, Jan; Di Ponzio, Chiara; Eils, Roland; Boulant, Steeve; Niopek, Dominik; Kallenberger, Stefan M.
title: Dynamics of SARS-CoV-2 host cell interactions inferred from transcriptome analyses
date: 2021-07-05
journal: bioRxiv
DOI: 10.1101/2021.07.04.450986
sha: 3ddfa7d8d18aa7ff25a45007bf3194f2c63df779
doc_id: 284603
cord_uid: tqvvdkrz

The worldwide spread of severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) caused an urgent need for an in-depth understanding of interactions between the virus and its host. Here, we dissected the dynamics of virus replication and the host cell transcriptional response to SARS-CoV-2 infection at a systems level by combining time-resolved RNA sequencing with mathematical modeling. We observed an immediate transcriptional activation of inflammatory pathways linked to the anti-viral response followed by increased expression of genes involved in ribosome and mitochondria function, thus hinting at rapid alterations in protein production and cellular energy supply. At later stages, metabolic processes, in particular those depending on cytochrome P450 enzymes, were downregulated. To gain a deeper understanding of the underlying transcriptional dynamics, we developed an ODE model of SARS-CoV-2 infection and replication. Iterative model reduction and refinement revealed that a negative feedback from virus proteins on the expression of anti-viral response genes was essential to explain our experimental dataset. Our study provides insights into SARS-CoV-2 virus-host interaction dynamics and facilitates the identification of druggable host pathways supporting virus replication.

The novel coronavirus SARS-CoV-2 is responsible for the worldwide coronavirus disease 2019 pandemic. Besides the respiratory epithelium of the nasopharynx and the lung, SARS-CoV-2 can infect different tissues of the human body including the mucosa of the intestine, the renal epithelium as well as lymphoid tissues (Gupta et al, 2020; Stanifer et al, 2020) . Recent studies based on transcriptomics and proteomics techniques revealed host cell pathways affected by SARS-CoV-2, characterized molecular interactions between virus-host protein interactions, identified host factors potentially serving as therapeutic targets and developed strategies for drug repurposing (Gordon et al, 2020a (Gordon et al, , 2020b Hadjadj et al, 2020; Bojkova et al, 2020; Klann et al, 2020; Blanco-Melo et al, 2020; Bouhaddou et al, 2020; Samavarchi-Tehrani et al, 2020; Schmidt et al, 2021; Selkrig et al, 2021; Stukalov et al, 2021; Triana et al, 2021; Wyler et al, 2021) . Analyses of the translatome and proteome in human colorectal adenocarcinoma cells showed that SARS-CoV-2 strongly affects translation, splicing, carbon metabolism and nucleic acid metabolism Klann et al, 2020) . A multi-omics study in a lung-derived cell line investigated virus-host protein interactomes and revealed that SARS-CoV-2 caused dysregulation of the TGF-β and EGFR pathways as well as autophagy (Stukalov et al, 2021) . Investigations of molecular interactions between virus and host proteins suggested immediate interactions with cellular pathways involved in inflammation such as NF-κB, interferon or mTOR signaling (Gordon et al, 2020b; Triana et al, 2021) . It was observed, for instance, that virus protein interactions with IL17RA immediately influence IL17 signaling. Virus proteins also directly interact with the mitochondrial outer membrane protein Tom70 that is involved in mitochondrial anti-viral signaling, through interaction with Hsp90, thereby affecting interferon signaling and apoptosis induction (Gordon et al, 2020a; Jiang et al, 2020; Stukalov et al, 2021; Samavarchi-Tehrani et al, 2020) . SARS-CoV-2 inhibits the type I interferon response to evade the cellular anti-viral defense (Blanco-Melo et al, 2020; Chu et al, 2020; Triana et al, 2021; Stukalov et al, 2021) .

Analyses of phospho-proteomes further revealed that kinases involved in growth factor receptor signaling become activated upon SARS-CoV-2 infection (Bouhaddou et al, 2020; Klann et al, 2020; Stukalov et al, 2021) . While kinases of the p38 pathway associated with inflammatory signaling were also triggered by SARS-CoV-2, Rho-associated protein kinases affecting organization of the interface between cytoskeleton and the plasma membrane were, in turn, inhibited. Moreover, phosphorylation of RNA-processing proteins was observed, which could indicate a strategy of the virus to prioritize translation of virus proteins over host cell proteins (Bouhaddou et al, 2020) . Apart from affecting host proteins via specific interactions, SARS-CoV and SARS-CoV-2 both perturb the integrity of host cells through fragmentation of the Golgi apparatus and formation of viral replication organelles consisting of double-membrane vesicles tethered to the endoplasmic reticulum (Knoops et al, 2008; Snijder et al, 2020; Cortese et al, 2020) .

Previous studies revealed several aspects of the host cell response on a qualitative level.

However, a fine-grained temporal and quantitative analysis of the host cell response, in particular, in the early phase of SARS-CoV-2 infection, would be important and necessary for understanding SARS-CoV-2 infection at a systems level. Here, we developed a systems biology approach for studying transcriptional dynamics based on time-resolved RNA sequencing (RNA-seq) experiments analyzed using a set of expression profile functions fitted to all expressed genes. This enabled us to dissect the timing and interdepence of cellular processes that oppose or support virus replication. Using highly infectable Caco-2 (human colon cancer) cells as a model system, we observed a characteristic time-pattern of transcriptional upregulation associated with pathways involved in inflammation, kinase signaling, and processes related to cellular energy production, followed by transcriptional downregulation of various metabolic processes. We then developed a mathematical model of SARS-CoV-2 replication calibrated with experimental measurements and applied model reduction strategies to identify pathophysiologically required interactions between the virus and its host. Finally, we explored different strategies for direct and indirect interference with virus replication. Our study provides novel insights into the temporal pattern of host-virus interactions and can serve as a resource to develop strategies for combined targeting of cellular processes that support virus replication.

The dynamics of SARS-CoV-2 infection at the cellular level were studied using the model system of Caco-2 (human colorectal adenocarcinoma) cells. First, we compared two independent Caco-2 cell lineages. We observed striking differences in their infectivity which corresponded to the detected differences in ACE2 and cathepsin B expression (see Supplementary note S1, Supplementary Fig. S1 ). Using the high ACE2/cathepsin B Caco-2 lineage, we then infected cells at a multiplicity of infection (MOI) of 5 and collected RNA samples at eight time points between 0 and 48 hours post infection (hpi) followed by RNA-seq ( Fig. 1A) . In parallel, we detected cells expressing SARS-CoV-2 N protein by immunostaining ( Fig. 1B) . We observed that virus transcripts rapidly increased and peaked already at 12 hpi, amounting to about one third of all detected transcripts (Fig. 1C) . Thereafter, virus transcripts decreased to about 17% of detected transcripts at 48 hpi. Read counts normalized to lengths of coding sequences (CDS) reflected the nested RNA architecture of nidovirales ( Fig. 1D and Supplementary Fig. S2 ). Virus N proteins were detected in about one third of cells by immunostaining already at 4 hpi and the number of N protein positive cells increased to 100% within only 24 hours (Fig. 1E ). Concurrently, the N protein expression levels per cells also increased ( Fig. 1B) . Cell counts remained constant until 24 hpi and decayed thereafter due to host cell death (Fig. 1F ). The timing of virus release was aligned to the timing of host cell death, suggesting that virus particles were mostly released through cell lysis rather than budding from the plasma membrane of living cells (Fig. 1G ). Taken together, SARS-CoV-2 replication was remarkably fast, resulted in high virus transcript loads already at 12 hpi and cell death, hence reflecting the typical characteristics of lytic viruses.

To characterize the transcriptional response in host cells upon SARS-CoV-2 infection, we analyzed changes in transcriptomes over time, first at the macroscopic level. Distributions of log2 fold changes of gene expression (L) indicated a fraction of strongly upregulated genes (defined by L ≥ 1) that was highest between 4 and 12 hpi ( Fig. 2A , at maximum 6.54%). In contrast, the fraction of genes for which expression was strongly downregulated (defined by L  − 1) steadily increased between 4 hpi and 48 hpi (Fig 2A, at maximum 4.15%). We conclude that the host response shows a characteristic, rapid upregulation in a fraction of genes within the first few hpi, followed by a phase of downregulation towards later time points.

Next, to identify cellular processes underlying these dynamics, the time series of log2 fold changes in transcript counts were subjected to gene ontology (GO) term enrichment analysis in interpolated hourly time intervals. We then clustered time courses of p-values indicating GO term enrichment. Three qualitatively different patterns of early, late or continuously regulated cellular processes were observed (Fig. 2B ). Cluster I, the cluster overrepresented within the first 12 hpi, contained several GO terms associated with mRNA biogenesis such as 'nucleartranscribed mRNA catabolic process', 'RNA processing', 'RNA metabolic process' or 'RNA splicing' (Fig. 2B , cluster I). Cluster II, the cluster overrepresented in late time points of infection, contained various GO terms involved in cellular metabolism including the terms 'steroid metabolic process', 'organic acid metabolic process', 'hormone metabolic process' as well as processes involved in the cellular response to drugs and chemical agents such as 'antibiotic metabolic process', 'xenobiotic metabolic process', 'drug metabolic process' or 'cellular response to chemical stimulus'. Cluster III, the cluster which represents continuously regulated processes, contained GO terms involved in cytokine signaling and the cellular stress response. These results suggest that upon SARS-CoV-2 infection, a rapid transcriptional response takes place well before high virus transcript levels are detectable (Fig. 1C) . The observed transcriptional regulation can be separated into cellular processes already influenced in the first hours after infection, delayed effects appearing after 12 hpi, i.e. when the amount of virus transcripts already starts to decrease, and gradually affected cellular processes.

Next, we analyzed temporal sequences and amplitudes of transcriptional changes associated with cellular processes and signal transduction pathways. Taking into account that cellular processes were continuously or transiently affected, we fitted four profile functions to log2 fold changes in all = 13,322 expressed genes. The functions described a continuous or transient increase or decrease in gene expression (Fig. 3A) . Profile function fits were then used to extract time points of expression changes, defined by the times at half-maximal increase or decrease, as well as amplitudes. To focus on curated graphs of signaling pathways, we analyzed transcriptional effects mapped to the KEGG database (Kanehisa & Goto, 2000; Kanehisa et al, 2019) . To visualize temporally ordered expression changes in cellular processes, we then created time-resolved pathway charts of strongly affected genes defined by absolute values of log2 fold changes | | ≥ 1. To identify strongly affected cellular processes and study the temporal order of transcriptional responses connected to these processes, we determined absolute numbers and fractions of strongly up-or downregulated genes, defined by | | ≥ 1, in all KEGG pathways (Fig. 4) .

Pathways with largest absolute numbers were 'Transcription factors', 'Membrane trafficking', 'Chromosome and associated proteins', 'Exosome' as well as 'Peptidases and inhibitors' (Fig.   4A ). Consistent with our analysis based on GO terms, the pathways 'Cytochrome P450' and 'Cytokines and growth factors' were among those with largest fractions of strongly affected genes (Fig. 4B ). To analyze the timing of effects in pathways, we extracted time points, at which 50% of the affected genes were regulated. To this end, cumulative sums of time intervals with increased expression of strongly regulated genes were determined. The top 25 up-and downregulated pathways, with the largest fractions of strongly regulated genes were then sorted according to times when 50% of genes were affected (Fig. 4C, D) . We observed an early response in several pathways associated with inflammation and cytokine signaling (e.g., 'Viral protein interaction with cytokine and cytokine receptors', 'IL-17 signaling pathway', 'TNF signaling pathway', 'Cytokine-cytokine receptor interaction') already around 1 hpi (Fig. 4C ).

Sets of genes upregulated in 'IL-17 signaling pathway', 'TNF signaling pathway' or 'Cytokinecytokine receptor interaction' showed large intersections with other pathways involving kinase signaling as 'MAPK signaling pathway' or 'PI3K-Akt signaling pathway' (Supplementary Fig.   S3A -E). Thereafter, around 2 hpi, several processes related to translation and production of chemical energy in mitochondria became upregulated, such as 'Ribosome', 'Thermogenesis' or 'Oxidative phosphorylation' (Fig. 4C) . Several pathways ranked among those with largest fractions of strongly upregulated genes because they contain many genes involved in mitochondria or ribosomes (green and blue font in Fig. 4C ; pathway charts for 'Ribosome' and 'Thermogenesis' in Supplementary Fig. S3G , H). Among these was the pathway 'Coronavirus disease -COVID-19' (Supplementary Fig. S3Q ) that contains various genes involved in ribosome function. Interestingly, all of these pathways were upregulated before virus transcript levels strongly increased (Fig. 4C, top panel) . In most cases, upregulation was reverted between 24 and 48 hpi, i.e. when cells died and virus particles were released (Fig. 1F , G).

The top 25 pathways with largest fractions of strongly downregulated genes showed that the gene expression mostly declined at later time points (Fig. 4D) . Specifically, two phases of downregulation could be observed, a first phase between 4 and 12 hpi, i.e. when virus transcript levels peaked, and a second phase between 12 and 48 hpi, i.e. when virus transcript levels decreased (Fig. 4D ). Around 4 hpi, the pathway 'Cytokine receptors' was downregulated subsequent to the early upregulation of several pathways depending on cytokines (compare Fig   4C and D) . The initially upregulated pathways 'Cytokine-cytokine receptor interaction', 'Viral protein interaction with cytokine and cytokine receptors' and 'Fat digestion and absorption', were downregulated at times when large virus transcript levels were present between 4 and 24 hpi ( Fig 4C and D) . Strongly downregulated pathways included several cellular processes involved in metabolism such as 'Protein digestion and absorption', 'Steroid hormone biogenesis', 'Cholesterol metabolism' or 'PPAR signaling pathway'. Strikingly, multiple pathways related to xenobiotic metabolism depending on cytochrome P450 enzymes were affected as part of the second phase of downregulation between 24 and 48 hpi (Fig. 4D ). The observation that several unexpected pathways as 'Bile secretion' emerged from our analysis can be explained by intersections of genes involved in common metabolic processes. Large intersections of genes, for instance, were present between the pathways 'Bile secretion' and 'Ovarian steroidogenesis' with pathways related to xenobiotic metabolism, as well as between 'Central carbon metabolism in cancer' and 'Cytokine receptors'. Several enzymes involved in the metabolism of specific drugs, including CYP2B6, CYP2C19 or CYP3A5 were downregulated ('Drug Metabolism -cytochrome P450' pathway, Supplementary Fig. 3K ). The pathway 'Complement and coagulation cascades', that was downregulated mostly between 12 and 48 hpi, contains several protease inhibitors from the serpin superfamily, such as SERPINA1 (1-antitrypsin), SERPINA5 (protein C inhibitor), SERPINC1 (antithrombin III), SERPIND1 (heparin cofactor II) or SERPINF2 (2-plasmin; Supplementary Fig. S3J ). Of these, SERPINA1 and SERPINA5 serve as inhibitors of the host-factor proteases for SARS-CoV-2, TMPRSS2 and cathepsin L (Fortenberry et al, 2006; Wettstein et al, 2021) . Further serpins, such as SERPINB8, an inhibitor of the host-factor protease furin (Dahlen et al, 1998) , were downregulated as part of the pathway 'Peptidases and inhibitors' (Supplementary Fig. 3R ).

Moreover, we observed downregulation of ACE2 as part of the 'Peptidases and inhibitors' pathway, mirroring previous findings in SARS-CoV-infected Vero cells and human intestinal organoids (Glowacka et al, 2010; Stanifer et al, 2020) .

In summary, we observed a sequence of early upregulation of transcription in pathways related to inflammation and cytokine signaling followed by upregulation in pathways associated with translation and chemical energy production between 1 and 4 hpi. Eventually, several pathways involved in cellular metabolism, particularly in xenobiotic metabolism, were strongly downregulated.

To obtain mechanistic insights to the dynamics of SARS-CoV-2 replication in conjunction with the anti-viral response in host cells, we developed mathematical models consisting of coupled ordinary differential equations. We aimed at finding a parsimonious model, with minimal complexity, to identify interactions required for explaining our experimental dataset. In the optimal model version, virus transcripts evoke transcription of mRNAs of anti-viral response genes (Fig. 5A ). These are translated to anti-viral proteins that inhibit virus replication.

This assumption of a direct interference with virus replication was motivated by the evidence that host-cell proteins that are part of the anti-viral response cause nonsense-mediated mRNA decay (NMD) in SARS-CoV-2 and other coronaviruses (Wada et al, 2018; Schmidt et al, 2021) . Several strategies used by SARS-CoV and SARS-CoV-2 to evade the host cell anti-viral response and perturb translation in host cells were previously described and translated to possible model extensions as described below. It was shown that SARS-CoV-2 inhibits the antiviral interferon response at the transcriptional and proteome levels (Hadjadj et al, 2020; Stukalov et al, 2021) . Previous studies also found that SARS-CoV actively inhibits host cell translation (Narayanan et al, 2008; Nakagawa et al, 2016) through the interaction of nsp1 and the 40S ribosomal subunit and inducing cleavage of host cell mRNAs (Kamitani et al, 2006 (Kamitani et al, , 2009 Huang et al, 2011) . Furthermore, the nsp1 protein of SARS-CoV counteracts host cell translation by inhibiting the 48S initiation complex formation (Lokugamage et al, 2012 ).

Therefore, we tested whether including the following components improved the model, based on reductions in BIC: (1) In conclusion, a mathematical model was developed that is capable of describing the dynamics of SARS-CoV-2 replication and the anti-viral response. Model discrimination suggested a strong inhibitory effect of SARS-CoV-2 proteins on the anti-viral response, and strong oversaturation of the translation of virus transcripts as well as the induction of anti-viral genes.

Subsequent to characterizing the cellular processes affected by SARS-CoV-2, we investigated two complementary strategies for interfering with virus replication. First, we developed an approach for experimentally characterizing direct inhibitors of SARS-CoV-2 protein maturation. Then, indirect inhibitors of host cell pathways presumably supporting virus replication were tested.

SARS-CoV-2 replication requires auto-catalytic cleavage of the precursor proteins pp1a and pp1ab by the 3C-like protease (3CL pro ; also referred to as M pro ), which represents a potential drug target for direct interference with virus replication. To monitor the activity of 3CL pro and effects of possible protease inhibitors, we developed a live-cell assay based on fluorescent cleavage probes. These probes comprised a fusion of a nuclear export sequence (NES), a peptide sequence specifically cleaved by 3CL pro and GFP (Fig. 6A ). Before cleavage, probes are restricted to the cytoplasm. Following cleavage-mediated removal of the NES, GFP can enter the nucleus and equilibrates between nucleus and cytoplasm. Probe cleavage in single cells can hence be followed in real time by confocal live-cell imaging and quantified using the GFP fluorescence intensity in the nucleus and cytoplasm . We assumed that the

Peptide sequences of all 11 cleavage sites processed by 3CL pro were integrated in cleavage probes (Supplementary Table S1 ), which were co-expressed with 3CL pro in HEK293T cells.

Using GFP-immunoblotting, we found that all probes were cleaved albeit with varying efficiency ( Supplementary Fig. S8 ). In line with recent studies, we observed that the broadspectrum coronavirus protease inhibitor GC376 could prevent probe cleavage ( Fig. 6B ) (Vuong et al, 2020; Fu et al, 2020) , as indicated by a predominant cytoplasmic fluorescence. After washing cells with medium lacking the inhibitor, the nuclear fluorescence increased indicating probe cleavage (Fig. 6B, C) . Re-adding GC367 resulted in inhibition of 3CL pro as indicated by a decrease of the nuclear and an increase of the cytoplasmic fluorescence intensity due to resynthesis of intact probes and degradation of cleavage products. Collectively, the developed live-cell assay can be used for testing potential inhibitors of 3CL pro and studying the kinetics of protease inhibition in single cells. Subsequently, we tested whether GC367 could inhibit SARS-CoV-2 replication in our experimental system (see below).

In addition to blocking SARS-CoV-2 polyprotein cleavage, we tested complementary strategies for indirect interference with virus replication. As shown by our transcriptomic analyses, SARS-CoV-2 infection results in rapid transcriptional upregulation in pathways involved in kinase signaling as the IL17, TNF, MAPK or PI3K/Akt pathways as well as processes involved in translation and production of chemical energy that likely support SARS-CoV-2 replication (Fig. 4C) . The PI3K/Akt/mTOR and MAPK pathways control translation based on phosphorylation of eukaryotic translation initiation factors (eIFs) and associated regulators (Roux & Topisirovic, 2012) . It was previously shown that activation of mTOR signaling regulates energy metabolism and stimulates mitochondrial activity as well as biogenesis thereby increasing the capacity for ATP production (Cunningham et al, 2007; Düvel et al, 2010; Morita et al, 2013) . Based on this hypothesis, it is reasonable to assume that inhibiting these pathways might counteract virus replication. Therefore, we tested the effect of metformin, an inhibitor of the NF-κB and the PI3K/Akt/mTOR pathways (Dowling et al, 2007; Hattori et al, 2006; Kalender et al, 2010; Moiseeva et al, 2013; Green et al, 2010) , and an inhibitor of mRNA translation in cancer cells (Zakikhani et al, 2006) , on virus replication. Moreover, we analyzed whether dexamethasone might have an immediate effect on virus replication, due to its catabolic function, its inhibitory effect on pro-inflammatory pathways at the transcriptional level and inhibition of mTOR (Shah et al, 2000; Wang et al, 2006; Quatrini & Ugolini, 2021 ).

Furthermore, we tested sorafenib, a broad-spectrum kinase inhibitor. Virus replication in presence or absence of the respective drugs was assessed by immunofluorescence staining of SARS-CoV-2 N protein at 24 hpi. While neither metformin nor dexamethasone had an inhibitory effect on virus replication, we found that sorafenib could inhibit SARS-CoV-2 replication with and IC50 concentration of 765 nM (Fig. 6D ). This observation is in line with previous studies . Furthermore, GC376 also potently inhibited SARS-CoV-2 replication with an IC50 concentration of 244 nM (Fig. 6D) , which is in line with recent findings by others (Vuong et al, 2020; Fu et al, 2020) .

In conclusion, our 3CL pro probe cleavage assay can be applied to screen for direct inhibitors of SARS-CoV-2 replication and characterize the dynamics of inhibitor binding and release. We found that direct as well as indirect interference with SARS-CoV-2 replication was effective in our experimental system. Interestingly, we observed a striking difference between indirect inhibitors of the mTOR pathway and the multi-kinase inhibitor sorafenib, suggesting that a specific subset of kinases could serve as optimal target(s) to counteract SARS-CoV-2

replication. To identify cellular processes that are essential for explaining SARS-CoV-2 replication in our experimental system, we developed a model that was devoid of mechanistic details in contrast to previous ODE-models of RNA virus replication that included aspects as positive and negative RNA strands, virus particle formation or shuttling between cellular compartments (Binder et al, 2013; Aunins et al, 2018; Zitzmann et al, 2020; Lopacinski et al, 2021) . Modeling showed that taking into account the inhibition of the transcription of anti-viral response genes by virus proteins was required to explain our experimental dataset. Modeling further suggested that the cellular anti-viral response resulted in a decrease of virus transcripts, but was nevertheless insufficient in preventing virus production and cell death. Our analysis and modeling inferred a sequence of events comprising (1) Focusing on the dynamics of the transcriptional response in cells infected with SARS-CoV-2 and the temporal order of affected cellular processes, we could observe a rapid sequence of upregulation in pathways related to cellular inflammation shortly after virus entry. This was followed by upregulation in processes associated with protein synthesis and production of chemical energy, all of which occurred before virus transcript levels strongly increased.

Upregulation in the latter processes likely results from a particularly high energy demand during virus replication. Hijacking of the cellular metabolism related to processes such as glycolysis, nucleotide or lipid synthesis was observed before in several viruses and can be compared to metabolic reprogramming in cancer cells (Thaker et al, 2019) . Host pathway upregulation mostly occurred prior to the time when large virus transcript levels were present and decreased after 24 hpi when cells died and virus particles were released. Besides an early transcriptional upregulation in pathways related to inflammation, such as the IL-17 or TNF signaling pathways, we observed an early transcriptional upregulation in pathways depending on kinase signaling such as the PI3K/Akt/mTOR or MAPK pathways. A causal link between the early transcriptional upregulation in the PI3K/Akt/mTOR pathway and later upregulation of mitochondrial and ribosomal genes can be hypothesized because it is known that this pathway is involved in the control of the biogenesis of mitochondria and ribosomes (Iadevaia et al, 2012 ). Previously, it was shown that NF-κB signaling is linked to upregulation of mitochondrial respiration (Mauro et al, 2011) . It was further observed that PI3K/mTOR inhibition decreased c-Myc induction and inhibited influenza virus replication (Smallwood et al, 2017) , which indicates that transcriptional upregulation of this pathway is part of the host cell responses that support virus replication. A recent study showed that SARS-CoV-2 limits AMPK/mTORC1 activation and autophagy, and that virus propagation is inhibited by the Akt inhibitor MK-2206 (Gassen et al, 2020) . Taken together, the host cell response dynamics is characterized by early activation of pathways involved in inflammation and kinase signaling followed by transcriptional upregulation of processes apparently supporting virus replication.

Interestingly, we observed downregulation of xenobiotic metabolism involving cytochrome To expedite the identification and characterization of direct inhibitors of virus protein maturation, we developed a cleavage probe assay that can indicate the activity of the SARS-CoV-2 3CL pro and evaluated the assay using the protease inhibitor GC376. In the future, this assay could be used to screen for further 3CL pro inhibiting drugs. Moreover, in our experimental setup of highly infectable Caco-2 cells, we could indeed confirm the effect of GC376 and sorafenib as direct and indirect inhibitors of SARS-CoV-2 replication, respectively (Vuong et al, 2020; Fu et al, 2020; Klann et al, 2020) . On the other hand, metformin and dexamethasone, which are indirect inhibitors of mTOR signaling, did not prevent virus replication. This suggests that the therapeutic effect of dexamethasone is restricted to its established function in limiting the inflammatory response in COVID-19 (Tomazini et al, 2020; RECOVERY Collaborative Group et al, 2021) .

Collectively, by integrating information on the dynamics of SARS-CoV-2 replication and transcription in host cells, our study sheds light on the dynamics of cellular regulatory processes involved in SARS-CoV-2 infection at a systems level. In particular, the sequential transcriptional activation of inflammatory pathways linked to the anti-viral response followed by upregulation of processes supporting virus replication and late downregulation of metabolic processes before cell death and virus release could be characterized. Our study provides additional insights into the orchestrated SARS-CoV-2 host interactions and could facilitate the development of strategies for combined drug interference with virus replication and cellular processes supporting virus biogenesis. 

Vero E6 cells were seeded into a 96-well plate 24 h prior to infection using 20,000 cells per well. A volume of 100 µl of viral supernatant was added to the first well, followed by seven 1:10 dilutions that were added to subsequent wells. All experiments were performed in triplicates. Infections were allowed to proceed for 24 h. At 24 hpi, cells were fixed in 2% paraformaldehyde (PFA) for 20 minutes at room temperature (RT). PFA was removed and cells were washed twice in 1×PBS and then permeabilized for 10 min at RT in 0.5% Triton X-100.

Cells were blocked in a 1:2 dilution of LI-COR blocking buffer (LI-COR, Lincoln, NE, USA)

for 30 min at RT. Cells were stained with 1/1,000 dilution anti-dsRNA (J2) for 1 h at RT. Cells were washed three times with 0.1% Tween in PBS. Secondary antibody (anti-mouse CW800) and DNA dye Draq5 (Abcam, Cambridge, UK) were diluted 1/10,000 in blocking buffer and incubated for 1 h at RT. Cells were washed three times with 0.1% Tween/PBS. Washing buffer was replaced by 1×PBS (without Tween), and samples were imaged using a LI-COR imager.

RNA was extracted from infected or mock-treated Caco-2 cells at 0, 1, 2, 4, 7, 12, 24 and 48 hpi using the Qiagen RNAeasy plus extraction kit (Qiagen, Hilden, Germany). For quantifying SARS-CoV-2 genome abundance in mock samples, cDNA was made using iSCRIPT reverse transcriptase (BioRad, Hercules, CA, USA). q-RT-PCR was performed using iTaq SYBR green 

Cleavage probes for monitoring the SARS-CoV-2 main protease activity were created by inserting 3CL pro targeted sequences in between an NES sequence (MNLVDLQKKLEELELDEQQ) and mGFP. To this end, the NES-mGFP encoding vector previously reported by us (Beaudouin et al, 2013) was linearized via unique AgeI/NotI restriction sites, and cleavage probes were inserted by oligo cloning. To generate a construct for co-expressing mCherry and SARS-CoV-2 main protease (3CL pro ), a fragment encoding 3CL pro was first obtained as a double-stranded DNA fragment (gBlock; IDT, San José, CA, USA) and cloned into pcDNA3.1(-) via unique NheI/NotI restriction sites. A fragment encoding mCherry followed by a P2A peptide sequence was also obtained as gBlock. The 3CL pro encoding vector was then linearized 5' of the 3CL pro start codon via NheI and the mCherry-P2A fragment was inserted via Gibson Assembly, hence yielding a vector encoding mCherry-P2A-3CL pro .

One day before transfection, 10 5 cells per well were seeded in 6-well plates. Cells were cotransfected with constructs encoding a cleavage probe and either (1) 3CL pro -2A-mCherry (2) a control vector lacking 3CL pro (Kallenberger et al, 2014) . 

Read pairs from triplicate samples of infected cells at 0, 1, 2, 4, 7, 12, 24 and 48 hpi and additional mock samples at 4, 12 and 48 hpi were mapped to a merged reference comprising the human reference genome (GRCh38.p13, NCBI build 38 path release 13 obtained from Genome Reference Consortium) and SARS-CoV-2 reference (NC_045512.2, NCBI reference sequence for SARS-CoV-2 isolate Wuhan-Hu-1). For read alignment, the STAR software was used with default settings (Dobin et al, 2013) . Subsequently, BAM files were split by their reference using the SAMtools software suite (Li et al, 2009 ) and counted separately using the featureCounts function from the Subread package (Liao et al, 2019) . Host reads were counted by the 'Exon' feature, whereas SARS-CoV-2 mapping reads were counted by the 'CDS'

feature. Transcript read counts were processed using 'DESeq2' (Love et al, 2014) . At first, log2

fold changes were calculated relative to a reference comprising measurements of samples were then used for GO term enrichment analysis (Ashburner et al, 2000; Gene Ontology Consortium, 2021) . For cluster analysis, and for visualizing transitions between GO-terms, log2

fold changes were interpolated in hourly time intervals between 0 and 48 hpi. Overrepresented GO terms were inferred using the 'goana' and 'topGO' function from the limma package (Ritchie et al, 2015) . As input, we used all genes with an absolute log2 fold change larger than one. Besides the gene label, we explicitly used the trend or abundance parameter in the 'goana'

function (mean expression of gene at timepoint ). We subsequently selected the top GO terms for each discrete time point and visualized negative log-scaled p-values in a clustered heatmap.

We applied hierarchical clustering using the Euclidean distance norm and complete linkage as implemented in the 'hclust' function of the 'stats' package.

To extract time points when gene expression was strongly affected and determine amplitudes of expression changes in all expressed host cell genes, profile functions were defined. Log2 fold changes were fitted by four profile functions The optimal function was selected using the Bayesian information criterion

that depends on the logarithm of the likelihood function maximum ̂, the number of parameters and the number of datapoints . Parameters were log-scaled to facilitate convergence of fits. For each profile function, 100 multi-start local optimizations were performed.

Model simulations were performed with custom scripts in MATLAB (The Mathworks, Natick, MA, USA). The MATLAB toolbox PottersWheel was used for model fitting (Maiwald & Timmer, 2008 Model equations of all variants are listed in Supplementary Table S1 ; parameter estimates of the optimal model variant '4.0.1' including allowed parameter intervals and 1σ-confidence intervals estimated based on the inverse of the Hessian matrix are given in Supplementary Table   S2 . and proteins as well as mRNAs and proteins associated with the anti-viral response (lines, predictions using means of parameters from best 10 of 5000 fits; shaded areas, 1σ-confidence intervals; a. u., arbitrary units). Cleavage probes consisting of a nuclear export sequence (NES), a 3CL pro cleavage site (NS4-NS5) and GFP were expressed in HEK293T cells. Uncleaved probes are continuously exported from the nucleus and hence located in the cytoplasm. Following 3CL pro -mediated cleavage, GFP enters the nucleus by diffusion. The cytoplasmic and nuclear fluorescence intensities (Icpl, Incl) were used to calculate the concentration of the uncleaved probe. (B, C) HEK293T cells coexpressing a cleavage probe containing the cleavage site between NSP4 and NSP5 and 3CL pro were incubated in presence of 20 mM GC376, the drug was removed at time point 0 and readded at 250 minutes (scale bar, 10 µm). Representative microscopy images (B) and corresponding quantification of the concentration of the uncleaved probe over time (C). Nuclear signal increase following GC376 removal indicates probe cleavage (data in C, means of n=10 cells, error bars: SEM). (D) Caco-2 cells were infected in the presence or absence of inhibitors. Virus replication was assessed at 24 hpi via immunofluorescence of SARS-CoV-2 N protein (means of n=3 replicates, error bars: SEM).

Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium

Intracellular Hepatitis C Virus Modeling Predicts Infection Dynamics and Viral Protein Mechanisms

Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells

Replication vesicles are loadand choke-points in the hepatitis C virus lifecycle

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19

Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies

Mootha VK & Puigserver P (2007) mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex

Inhibition of soluble recombinant furin by human proteinase inhibitor 8

Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients

STAR: ultrafast universal RNA-seq aligner

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1

Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics

The Gene Ontology resource: enriching a GOld mine

Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTORdependent oncogenic mRNA translation

Extrapulmonary manifestations of COVID-19

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Metformin Inhibits Cytokine-Induced Nuclear Factor κB Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells

SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage

Roles of the mammalian target of rapamycin, mTOR, in controlling ribosome biogenesis and protein synthesis

SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner

Intra-and interdimeric caspase-8 self-cleavage controls strength and timing of CD95-induced apoptosis

A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein

Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation

KEGG: kyoto encyclopedia of genes and genomes

New approach for understanding genome variations in KEGG

Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication

SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum

Evaluation of human hepatocytes under prolonged culture in a novel medium for the maintenance of hepatic differentiation: results with the model pro-inflammatory cytokine interleukin 6

The Sequence Alignment/Map format and SAMtools

The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads

Severe acute respiratory syndrome coronavirus protein nsp1 is a novel eukaryotic translation inhibitor that represses multiple steps of translation initiation

Modeling the complete kinetics of coxsackievirus B3 reveals human determinants of host-cell feedback

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Dynamical modeling and multi-experiment fitting with PottersWheel

NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration

Effects of cytokines on CYP3A4 expression and reversal of the effects by anti-cytokine agents in the three-dimensionally cultured human hepatoma cell line FLC-4

Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation

mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational Regulation

Viral and Cellular mRNA Translation in Coronavirus-Infected Cells

Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells

New insights into the cell-and tissue-specificity of glucocorticoid actions

Dexamethasone in Hospitalized Patients with Covid-19

) limma powers differential expression analyses for RNA-sequencing and microarray studies

Regulation of mRNA translation by signaling pathways

A SARS-CoV-2 -host proximity interactome

The SARS-CoV-2 RNA-protein interactome in infected human cells

SARS-CoV-2 infection remodels the host protein thermal stability landscape

Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle

Targeting Metabolic Reprogramming by Influenza Infection for Therapeutic Intervention

A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis

Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV

Viral hijacking of cellular metabolism

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial

Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

Interplay between coronavirus, a cytoplasmic RNA virus, and nonsense-mediated mRNA decay pathway

Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1

Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection

Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

A Coupled Mathematical Model of the Intracellular Replication of Dengue Virus and the Host Cell Immune Response to Infection

We thank Thomas Wolf and Benedikt Brors for comments and valuable discussions. This work was supported by the fightCOVID-19 initiative of the German Cancer Research Center (Heidelberg, Germany). Furthermore, this work was supported by research grants from the Bundesministerium Bildung und Forschung (BMBF): project numbers 01KI20239B to MS, 031L0270 to SK (Computational Life Sciences program) and 01KI20198A to SB, the Deutsche